AlzeCure is part of the region’s world-leading research in healthy aging

Invest Stockholm has now updated its presentation of the region’s research and the companies working with neurodegenerative diseases. Here you will find, among others, AlzeCure, which is developing a painkiller based on this year’s Nobel Prize in Medicine.

Stockholm-Uppsala holds world-leading knowledge in the field of healthy aging. Invest Stockholm has made an extensive review of the region’s academic research in an updated report that also includes several selected companies.

Here is one of Flemingsberg’s knowledge companies: AlzeCure, which develops new innovative drug therapies for the treatment of severe diseases that affect the central nervous system, such as Alzheimer’s disease and pain.

The company is developing a painkiller based on a discovery by David Julius and Ardem Patapoutian who share this year’s Nobel Prize in Physiology or Medicine.

Read more about AlzeCure and the region’s leading research in the report: Improving Quality of Life for People with Neurodegenerative Diseases (pdf).

She’s Building Bridges Between People and Place – Meet Karin, the Placemaker Behind the Future of Flemingsberg

Karin Lekberg is paving the way for the Flemingsberg of the future — a place where knowledge and creativity meet. She envisions a vibrant area full of culture, evening and nightlife, and a natural meeting place for both students and creators. But when the goal feels far away, it’s about starting where you are — creating life and activity here and now, and above all, building on the stories that already exist, allowing the place to grow into its future.

Flemingsberg Brought Color to Nordic Life Science Days

Flemingsberg is a place where research and progress never sleep. A place where someone is always working on a solution. During Nordic Life Science Days in Gothenburg, Flemingsberg stood out from afar — with an orange booth that, just like Flemingsberg itself, was full of surprises, experiences, and served as an excellent meeting spot for life science enthusiasts.

OptiCell Solutions enters a research collaboration with Karolinska Institutet

With the goal of supporting academia, healthcare, and industry in developing the cell and gene therapies of the future, OptiCell Solutions established its operations in Flemingsberg last year. The company has now entered into a research collaboration with Karolinska Institutet, marking a significant step in the desired direction.

Do you want to know more?
Subscribe to our newsletter.

SUBSCRIBE

Do you want to know more?
Subscribe to our newsletter.

SUBSCRIBE
CF_logo_neg
2021-12-10T13:19:20+01:00

Want to know more? Subscribe to our newsletter.

SUBSCRIBE
CF_logo_neg

Want to know more? Subscribe to our newsletter.

CF_logo_neg
fb yt insta
fb yt insta
Go to Top